SCHEMBL3874785

SCHEMBL3874785

CCCCOC(=O)CCCCCCCCCl

nearest known ligand 0.68

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.68
DNM1 Q05193 1/20 0.56
PRSS1 P07477 1/20 0.53
PRSS2 P07478 1/20 0.53
PRSS3 P35030 1/20 0.53
NAAA Q02083 1/20 0.52
PAM P19021 2/20 0.52
HTR2C P28335 1/20 0.50
TSHR P16473 1/20 0.49
MAPT P10636 1/20 0.49
ALDH1A1 P00352 2/20 0.47
LMNA P02545 2/20 0.47
KDM4E B2RXH2 1/20 0.46
DUSP3 P51452 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
EPHX2 P34913 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1366402 1.00 DGKA (0.68) DGKADNM1PRSS1PRSS2PRSS3
SCHEMBL1369772 1.00 DGKA (0.68) DGKADNM1PRSS1PRSS2PRSS3
SCHEMBL1365016 1.00 DGKA (0.68) DGKADNM1PRSS1PRSS2PRSS3
SCHEMBL1365577 0.98 DGKA (0.64) DGKADNM1PRSS1PRSS2PRSS3
SCHEMBL11740012 0.94 DGKA (0.71) DGKADNM1PRSS1PRSS2PRSS3
SCHEMBL21811531 0.94 DGKA (0.71) DGKADNM1PRSS1PRSS2PRSS3
SCHEMBL21811462 0.94 DGKA (0.71) DGKADNM1PRSS1PRSS2PRSS3
SCHEMBL21811441 0.94 DGKA (0.71) DGKADNM1PRSS1PRSS2PRSS3
SCHEMBL21811778 0.94 DGKA (0.71) DGKADNM1PRSS1PRSS2PRSS3
SCHEMBL21811451 0.94 DGKA (0.71) DGKADNM1PRSS1PRSS2PRSS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7589156-B2 Polyhydroxyalkanoic acid having ester, carboxyl or sulfonic acid group, and producing method therefor CANON KABUSHIKI KAISHA (JP) 2009-09-15 US disclosed
US-7557176-B2 Polyhydroxyalkanoic acid having vinyl, ester, carboxyl or sulfonic acid group and producing method therefor CANON KABUSHIKI KAISHA (JP) 2009-07-07 US disclosed
EP-1758948-B1 POLYHYDROXYALKANOIC ACID HAVING VINYL, ESTER, CARBOXYL OR SULFONIC ACID GROUP AND PRODUCING METHOD THEREFOR CANON KK (JP) 2009-05-13 EP disclosed
US-7510813-B2 Resin-coated carrier for electrophotographic developer CANON KABUSHIKI KAISHA (JP) 2009-03-31 US disclosed
US-20080064828-A1 Polyhydroxyalkanoic Acid Having Vinyl, Ester, Carboxyl or Sulfonic Acid Group and Producing Method Therefor CANON KABUSHIKI KAISHA (JP) 2008-03-13 US disclosed
US-20070117937-A1 Polyhydroxyalkanoic acid having ester, carboxyl or sulfonic acid group and producing method thereor CANON KABUSHIKI KAISHA (JP) 2007-05-24 US disclosed
EP-1758948-A2 POLYHYDROXYALKANOIC ACID HAVING VINYL, ESTER, CARBOXYL OR SULFONIC ACID GROUP AND PRODUCING METHOD THEREFOR Canon Kabushiki Kaisha (JP) 2007-03-07 EP disclosed
US-20060194071-A1 Developer carrying member and development apparatus CANON KABUSHIKI KAISHA (JP) 2006-08-31 US disclosed
WO-2005121204-A2 POLYHYDROXYALKANOIC ACID HAVING VINYL, ESTER, CARBOXYL OR SULFONIC ACID GROUP AND PRODUCING METHOD THEREFOR CANON KABUSHIKI KAISHA (JP) 2005-12-22 WO disclosed
WO-2005121208-A1 POLYHYDROXYALKANOIC ACID HAVING ESTER, CARBOXYL OR SULFONIC ACID GROUP AND PRODUCING METHOD THEREFOR CANON KABUSHIKI KAISHA (JP) 2005-12-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064828-A1 Polyhydroxyalkanoic Acid Having Vinyl, Ester, Carboxyl or Sulfonic Acid Group and Producing Method Therefor FAR1, ACSL4, ACAD11 DGKA 846/4885DNM1 1181/4885PRSS1 1569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.